Your browser doesn't support javascript.
loading
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials.
Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Angel, Stephanie; Stilgenbauer, Stephan; Thurner, Lorenz; Bewarder, Moritz; Schwier, Maren; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Poeschel, Viola; Hellwig, Dirk.
Afiliación
  • Kaddu-Mulindwa D; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Kirrberger Str. 100, 66421, Homburg, Germany. dominic.kaddu@uks.eu.
  • Altmann B; Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany.
  • Held G; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Kirrberger Str. 100, 66421, Homburg, Germany.
  • Angel S; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Kirrberger Str. 100, 66421, Homburg, Germany.
  • Stilgenbauer S; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Kirrberger Str. 100, 66421, Homburg, Germany.
  • Thurner L; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Kirrberger Str. 100, 66421, Homburg, Germany.
  • Bewarder M; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Kirrberger Str. 100, 66421, Homburg, Germany.
  • Schwier M; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Kirrberger Str. 100, 66421, Homburg, Germany.
  • Pfreundschuh M; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Kirrberger Str. 100, 66421, Homburg, Germany.
  • Löffler M; Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany.
  • Menhart K; Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
  • Grosse J; Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
  • Ziepert M; Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany.
  • Herrmann K; Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
  • Dührsen U; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
  • Hüttmann A; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
  • Barbato F; Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
  • Poeschel V; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Kirrberger Str. 100, 66421, Homburg, Germany.
  • Hellwig D; Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
Eur J Nucl Med Mol Imaging ; 48(11): 3550-3559, 2021 10.
Article en En | MEDLINE | ID: mdl-33928400
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Fluorodesoxiglucosa F18 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Fluorodesoxiglucosa F18 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Alemania